3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
20
Neoplasm Metastasis
12
Prostatic Neoplasms
11
Neoplasms
8
Carcinoma, Hepatocellular
8
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Liver Neoplasms
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Pheochromocytoma
2
Paraganglioma
2
Neuroendocrine Tumors
2
Multiple Myeloma
2
Melanoma
2
Kidney Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Medullary
2
Carcinoid Tumor
2
Brain Neoplasms
2
Adenocarcinoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urethral Neoplasms
1
Interventions
Geriatric Assessment
4
Nutrition Assessment
2
epigallocatechin gallate
1
cabozantinib
1
Ultrasonography
1
Standard of Care
1
Restraint, Physical
1
Resistance Training
1
Qigong
1
Observation
1
Control Groups
1
Chemotherapy, Adjuvant
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Frailty
×
cabozantinib
×
Clear all
NCT04134390
2024-01-09
CABOMAYOR
Spanish Oncology Genito-Urinary Group
Phase 2
Completed
25 enrolled